News + Font Resize -

Aurobindo Pharma gets nod for Lisinopril pills in Australia
Our Bureau, Mumbai | Monday, March 2, 2009, 08:00 Hrs  [IST]

Aurobindo Pharma Limited has announced that its wholly-owned subsidiary Aurobindo Pharma Australia Pty Ltd has received its first approval from Therapeutic Goods Administration (TGA), Government of Australia for the registration of Auro-Lisinopril 5, Auro-Lisinopril 10 and Auro-Lisinopril 20 tablets containing Lisinopril (as dehydrate) 5mg, 10mg and 20mg.

The approval indications for these therapeutic products are for treatment of hypertension, congestive heart failure and acute myocardial infarction

Post Your Comment

 

Enquiry Form